Physician profile
Nancy Silva
NPI 1598757890
$421.75
in general payments reported to CMS, 2019-2025
11 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.65 · 2022: $98.38 · 2024: $117 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $106.72 | 2022-2025 | Azstarys |
| Tris Pharma INC | $75.24 | 2024-2025 | Dyanavel Xr |
| Sanofi-Aventis U.S. LLC | $61.45 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $46.99 | 2022-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Azurity Pharmaceuticals, INC. | $36.61 | 2025 | Alvesco |
| Ultragenyx Pharmaceutical INC. | $19.64 | 2024 | Crysvita |
| Sanofi Pasteur INC. | $15.65 | 2021 | |
| Alk-Abello, INC | $15.63 | 2025 | Neffy |
| Ironshore Pharmaceuticals INC. | $15.57 | 2024 | |
| Pfizer INC. | $14.66 | 2022 | |
| Neos Therapeutics, LP | $13.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.